Stay updated with breaking news from Screening Tests. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This 2023 Recommendation Statement from the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benef
The most common test used to check for colon cancer is the once-a-decade colonoscopy. But researchers say stool and blood tests could aid testing.
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that it has launched its blood-based colorectal cancer screening test, ShieldTM, in collaboration with Samsung Medical Center in South Korea.
This 2023 Recommendation Statement from the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benef
This 2023 Recommendation Statement from the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benef